Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mark W, Donoghoe"'
Autor:
Eden G. Robertson, Kate Hetherington, Rebecca Daly, Mark W. Donoghoe, Nicholas Handelsman, David S. Ziegler, Claire E. Wakefield
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Background Patient‐reported outcomes measures (PROMs) are increasingly being collected within cancer clinical trials, yet limited literature on the feasibility and acceptability of doing so. Methods We collected parent‐proxy and adolesce
Externí odkaz:
https://doaj.org/article/c410b79109df4d86876e4705fb6a2e02
Autor:
Clarissa E. Schilstra, Karen McCleary, Joanna E. Fardell, Mark W. Donoghoe, Emma McCormack, Rishi S. Kotecha, Richard De Abreu Lourenco, Shanti Ramachandran, Ruelleyn Cockcroft, Rachel Conyers, Siobhan Cross, Luciano Dalla-Pozza, Peter Downie, Tamas Revesz, Michael Osborn, Frank Alvaro, Claire E. Wakefield, Glenn M. Marshall, Marion K. Mateos, Toby N. Trahair
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Pediatric acute lymphoblastic leukemia (ALL) therapy is accompanied by treatment-related toxicities (TRTs) and impaired quality of life. In Australia and New Zealand, children with ALL are treated with either Children’s Oncology
Externí odkaz:
https://doaj.org/article/17592b5db9b04671b967107c72d358c2
Autor:
Angelique H. RIEPSAMEN, Mark W. DONOGHOE, Inthrani R. INDRAN, Shelly LIEN, Leah HECHTMAN, David M. ROBERTSON, Robert B. GILCHRIST, Eu-Leong YONG, William L. LEDGER
Publikováno v:
Fertility & Reproduction, Vol 04, Iss 03n04, Pp 141-141 (2022)
Background: The oocyte-secreted factors growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are key regulators of female fertility and are predominantly expressed by oocytes. Recently, methods to quantitate these proteins
Externí odkaz:
https://doaj.org/article/f07acbb27fe7488dad9f5fc2edd4d70e
Autor:
Mark W. Donoghoe, Ian C. Marschner
Publikováno v:
Communications in Statistics - Simulation and Computation. :1-18
Autor:
Mark W. Donoghoe, Ian C. Marschner
Publikováno v:
Journal of Statistical Software, Vol 86, Iss 1, Pp 1-22 (2018)
Relative risk regression using a log-link binomial generalized linear model (GLM) is an important tool for the analysis of binary outcomes. However, Fisher scoring, which is the standard method for fitting GLMs in statistical software, may have diffi
Externí odkaz:
https://doaj.org/article/9259858ee7ec403cb7132d8407aab8d9
Autor:
Aiat Shamsa, Robert B. Gilchrist, David M. Robertson, Rachael J. Rodgers, Mark W. Donoghoe, William L. Ledger, Jason A. Abbott, Angelique H. Riepsamen
Publikováno v:
Reproductive Sciences. 30:1521-1527
Abstract Oocyte-secreted growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) are critical paracrine regulators of female fertility. Recent studies demonstrated that serum concentrations are associated with the number of o
Autor:
Mark W. Donoghoe, Val Gebski
Publikováno v:
BMC Medical Research Methodology, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background The analysis of time-to-event data can be complicated by competing risks, which are events that alter the probability of, or completely preclude the occurrence of an event of interest. This is distinct from censoring, which merely
Externí odkaz:
https://doaj.org/article/282875d8f5c1404c832354cd820cd5f7
Autor:
Angelique H. Riepsamen, Mark W. Donoghoe, Inthrani R. Indran, Leah Hechtman, David M. Robertson, Robert B. Gilchrist, William L. Ledger, Eu‐Leong Yong
Publikováno v:
Clinical endocrinology.
Growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are critical paracrine regulators of female fertility and are predominantly expressed by oocytes. However, it is unknown if serum concentrations reflect changes in ovari
Autor:
Kate Hetherington, Claire E. Wakefield, Kavitha P. K. Kunalan, Mark W. Donoghoe, Brittany C. McGill, Joanna E. Fardell, Rebecca Daly, Rebecca J. Deyell, David S. Ziegler
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5310
Precision medicine is changing the treatment of childhood cancer globally, however little is known about quality of life (QoL) in children and adolescents participating in precision medicine trials. We examined QoL among patients enrolled in PRISM, t
Autor:
Ru-Dee, Ting, Anthony C, Keech, Paul L, Drury, Mark W, Donoghoe, John, Hedley, Alicia J, Jenkins, Timothy M E, Davis, Seppo, Lehto, David, Celermajer, R John, Simes, Kushwin, Rajamani, Kim, Stanton, R, Scott
Publikováno v:
Diabetes Care
OBJECTIVE Diabetic patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] 30–59 mL/min/1.73 m2) are at particular cardiovascular risk. Fenofibrate’s safety in these patients is an issue because it may elevate plasma